Scientists Explore Brain Link in Type 2 Diabetes Treatment
A new study has uncovered how Metformin affects the brain in people with Type 2 Diabetes. Researchers say the drug does more than control blood sugar. It may also work through specific brain mechanisms.
Metformin has been widely used for over 60 years. Doctors often prescribe it as a first-line treatment for diabetes. Until now, experts believed it mainly worked by reducing glucose production in the liver. Some studies also suggested it acts through the gut.
However, this new research shifts the focus to the brain. Scientists now believe the brain plays a key role in how the drug lowers blood sugar levels. These findings could change how future diabetes treatments are developed.
Key Role of Brain Protein Rap1 protein Identified
Researchers focused on a protein called Rap1 protein. This protein exists in a brain region known as the ventromedial hypothalamus. This area helps regulate energy balance and glucose metabolism.
The study showed that Rap1 plays an important role in controlling blood sugar. Scientists tested this by using genetically modified mice. These mice lacked the Rap1 protein in the targeted brain region.
Researchers then fed the mice a high-fat diet. This helped mimic conditions similar to type 2 diabetes. When low doses of metformin were given, the results showed little improvement in blood sugar levels.
In comparison, other treatments worked better. Therapies like insulin and GLP-1 agonists showed clear effects. This suggested that metformin needs Rap1 in the brain to work effectively.
Direct Brain Impact Could Transform Future Diabetes Therapies
Scientists then tested a new approach. They injected very small doses of Metformin directly into the brains of diabetic mice. The results were surprising. Blood sugar levels dropped significantly, even with extremely low doses.
This discovery highlights the brain’s direct involvement in glucose control. It also suggests that targeting the brain could improve treatment outcomes. Researchers believe this could lead to more precise and effective therapies.
Makoto Fukuda, a pathophysiologist involved in the study, explained the findings. He said scientists explored the brain because it controls whole-body metabolism. His team wanted to understand how the brain contributes to metformin’s effects.
The research also examined specific neurons affected by the drug. This step is important for future developments. Targeting these neurons could help create better treatments with fewer side effects.
The study was published in Science Advances. Experts say the findings open new doors in diabetes research. They also highlight the need to rethink how common medications work inside the body.
